封面
市場調查報告書
商品編碼
1775386

臨床試驗包裝市場:預測(2025-2030)

Global Clinical Trials Packaging Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

臨床試驗包裝市場預計將從 2025 年的 27.4 億美元成長到 2030 年的 41.39 億美元,複合年成長率為 8.60%。

全球臨床試驗包裝市場分析報告全面分析了滿足全球製藥和生物技術公司需求的臨床試驗包裝解決方案。本研究專為尋求深入了解該專業領域的市場動態、技術進步和競爭策略的行業專業人士量身定做。報告涵蓋產品類型、材料類型、包裝類型和區域格局,深入探討市場趨勢和機會,並特別關注競爭格局的最新發展。

市場概況和範圍

全球臨床試驗包裝市場分析報告探討了包裝在確保臨床試驗材料的完整性、安全性和合規性方面所發揮的關鍵作用。該市場涵蓋各種包裝解決方案,例如管瓶、泡殼、管、瓶、小袋、小袋、小袋和其他形式,並按材料(塑膠、玻璃、金屬、紙/紙板等)和包裝類型(一級、二級和三級)進行細分。分析涵蓋北美、南美、歐洲、中東和非洲以及亞太地區等主要地區,深入洞察區域市場動態和各國特定趨勢。報告還評估了市場促進因素(例如臨床試驗活動的增加)和限制因素(例如嚴格的監管要求),以提供對成長潛力的客觀觀點。

競爭格局與分析

臨床試驗包裝市場的競爭格局以策略創新和主要企業之間的聯盟為特徵。本節重點介紹主要市場參與企業的關鍵進展,以及他們為鞏固市場地位和滿足不斷變化的行業需求所做的努力。以下是主要參與者取得的兩項值得注意的進展:

  • Piramal Pharma Solutions:Piramal Pharma Solutions 近期透過對先進包裝技術的策略性投資,擴展了其臨床試驗包裝能力。 2024年,該公司推出了一系列整合物聯網追蹤系統的全新智慧包裝解決方案。這些解決方案增強了臨床試驗材料的即時監控,確保運輸過程中的溫度控制和防篡改。這項發展契合了國際臨床試驗(尤其是生技藥品和溫敏型治療產品)對安全合規包裝日益成長的需求。
  • 賽默飛世爾科技:賽默飛世爾科技在臨床試驗永續包裝方面取得了長足進步,推出了一系列面向2025年的環保包裝解決方案,包括生物分解性包裝袋和可回收二次包裝,旨在滿足環境法規要求的同時保持產品完整性。該舉措旨在響應監管機構和客戶日益成長的壓力,促使其在臨床試驗供應鏈中採用永續實踐。透過將永續性融入其包裝產品組合,賽默飛世爾科技不僅解決了環境問題,還吸引了那些重視環保實踐的製藥公司,從而幫助其提昇在臨床試驗包裝市場的佔有率。

這些發展反映了競爭格局的廣泛趨勢,智慧和永續包裝解決方案的創新正成為關鍵的差異化因素。本研究中的競爭分析還包括市場佔有率評估、併購和聯盟,從而全面展現了 Almac Group、Clinigen Clinical Supplies Management 和 PCI Services 等主要企業如何引領市場。競爭儀表板以可視化的方式呈現了這些動態,使行業專業人士能夠評估他們的策略定位和市場影響力。

戰略和技術見解

臨床試驗包裝市場研究深入探討了塑造該行業的先進技術,例如智慧包裝的採用和包裝流程的自動化。這些技術創新提高了效率,減少了錯誤,並確保遵守臨床試驗物流中至關重要的嚴格法規。該研究還包括波特五力分析,以評估競爭強度,以及產業價值鏈分析,重點在於從原料供應商到包裝服務供應商等關鍵相關人員的作用。研究還提供了策略建議,幫助企業抓住新機會,例如向亞太等高成長地區擴張以及投資永續包裝解決方案。

本報告的主要優點

  • 深刻分析:獲得涵蓋主要地區和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局:了解全球主要企業所採用的策略策略,並了解正確策略帶來的潛在市場滲透。
  • 市場促進因素和未來趨勢:探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
  • 可行的建議:利用洞察力進行策略決策,在動態環境中開闢新的業務流和收益。
  • 適用範圍廣:對於新興企業、研究機構、顧問公司、中小企業和大型企業來說,它都是實用且具有成本效益的。

它有什麼用途?

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

分析範圍

  • 歷史資料(2022-2024)和預測資料(2025-2030)
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按部門和地區(國家)分類的收益成長和預測分析
  • 公司概況(策略、產品、財務資訊、主要趨勢等)

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 研究範圍
  • 市場區隔

第3章 商業景氣

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章全球臨床試驗包裝市場(依產品類型)

  • 介紹
  • 管瓶
  • 泡殼
  • 管子
  • 瓶子
  • 小袋
  • 袋子和小袋
  • 其他

6. 全球臨床試驗包裝市場(依材料類型)

  • 介紹
  • 塑膠
  • 玻璃
  • 金屬
  • 紙和紙板
  • 其他

7. 全球臨床試驗包裝市場(依包裝類型)

  • 介紹
  • 初級包裝
  • 二次包裝
  • 三級包裝

8. 全球臨床試驗包裝市場(按地區)

  • 介紹
  • 北美洲
    • 依產品類型
    • 依材料類型
    • 按包裝類型
    • 按國家
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依產品類型
    • 依材料類型
    • 按包裝類型
    • 按國家
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依產品類型
    • 依材料類型
    • 按包裝類型
    • 按國家
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 依產品類型
    • 依材料類型
    • 按包裝類型
    • 按國家
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依產品類型
    • 依材料類型
    • 按包裝類型
    • 按國家
      • 中國
      • 日本
      • 印度
      • 韓國
      • 台灣
      • 其他

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 企業合併、協議、商業合作
  • 競爭儀錶板

第10章 公司簡介

  • Piramal Pharma Solutions
  • Almac Group
  • Thermo Fisher Scientific Inc.
  • Clinigen Clinical Supplies Management
  • Xerimis
  • PCI Services
  • SGS SA(Quay Pharma)
  • Bilcare Ltd
  • Lonza
  • Mikart, LLC

第11章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061613487

The Global Clinical Trials Packaging Market is expected to grow from USD 2.740 billion in 2025 to USD 4.139 billion in 2030, at a CAGR of 8.60%.

The Global Clinical Trials Packaging Market study provides a comprehensive analysis of the packaging solutions tailored for clinical trials, addressing the needs of pharmaceutical and biotechnology companies worldwide. This study is designed for industry experts seeking in-depth insights into market dynamics, technological advancements, and competitive strategies shaping this specialized sector. Covering product types, material types, packaging types, and geographic regions, the study offers a detailed examination of market trends and opportunities, with a particular focus on recent developments in the competitive landscape.

Market Overview and Scope

The Global Clinical Trials Packaging Market study explores the critical role of packaging in ensuring the integrity, safety, and compliance of clinical trial materials. It defines the market as encompassing packaging solutions such as vials, blisters, tubes, bottles, sachets, bags, pouches, and other formats, segmented by material (plastic, glass, metal, paper & paperboard, and others) and packaging type (primary, secondary, and tertiary). The analysis spans key regions, including North America, South America, Europe, Middle East and Africa, and Asia Pacific, providing granular insights into regional market dynamics and country-specific trends. The study also evaluates market drivers, such as increasing clinical trial activities, and restraints, including stringent regulatory requirements, to offer a balanced perspective on growth potential.

Competitive Environment and Analysis

In the Global Clinical Trials Packaging Market, the competitive environment is marked by strategic innovations and collaborations among key players. This section highlights significant developments from major market participants, focusing on their efforts to strengthen market positions and address evolving industry demands. Below are two notable developments from key players:

  • Piramal Pharma Solutions: Piramal Pharma Solutions has recently expanded its clinical trial packaging capabilities through strategic investments in advanced packaging technologies. In 2024, the company introduced a new line of smart packaging solutions integrated with IoT-enabled tracking systems. These solutions enhance real-time monitoring of clinical trial materials, ensuring temperature control and tamper-evidence during transportation. This development aligns with the growing demand for secure and compliant packaging in global clinical trials, particularly for biologics and temperature-sensitive therapies. Piramal's focus on technology-driven packaging positions it as a leader in addressing regulatory and logistical challenges, strengthening its competitive edge in the market.
  • Thermo Fisher Scientific Inc.: Thermo Fisher Scientific has made significant strides in sustainable packaging for clinical trials, launching a range of eco-friendly packaging solutions in 2025. These include biodegradable pouches and recyclable secondary packaging designed to meet environmental regulations while maintaining product integrity. This initiative responds to increasing pressure from regulatory bodies and clients to adopt sustainable practices in clinical trial supply chains. By integrating sustainability into its packaging portfolio, Thermo Fisher not only addresses environmental concerns but also appeals to pharmaceutical companies prioritizing green initiatives, enhancing its market share in the Global Clinical Trials Packaging Market.

These developments reflect broader trends in the competitive landscape, where innovation in smart and sustainable packaging solutions is becoming a key differentiator. The study's competitive analysis also includes market share evaluations, mergers, acquisitions, and collaborations, providing a holistic view of how major players like Almac Group, Clinigen Clinical Supplies Management, and PCI Services are navigating the market. The competitive dashboard offers a visual representation of these dynamics, enabling industry experts to assess strategic positioning and market influence.

Strategic and Technological Insights

The Global Clinical Trials Packaging Market study delves into technological advancements shaping the industry, such as the adoption of smart packaging and automation in packaging processes. These innovations enhance efficiency, reduce errors, and ensure compliance with stringent regulations, which are critical in clinical trial logistics. The study also includes a Porter's Five Forces analysis to evaluate competitive intensity and an industry value chain analysis to highlight key stakeholders' roles, from raw material suppliers to packaging service providers. Strategic recommendations are provided to help companies capitalize on emerging opportunities, such as expanding into high-growth regions like Asia Pacific or investing in sustainable packaging solutions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Product Type

  • Vials
  • Blisters
  • Tubes
  • Bottles
  • Sachets
  • Bags and Pouches
  • Others

By Material Type

  • Plastic
  • Glass
  • Metal
  • Paper & Paperboard
  • Others

By Packaging Type

  • Primary Packaging
  • Secondary Packaging
  • Tertiary Packaging

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Vials
  • 5.3. Blisters
  • 5.4. Tubes
  • 5.5. Bottles
  • 5.6. Sachets
  • 5.7. Bags and Pouches
  • 5.8. Others

6. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY MATERIAL TYPE

  • 6.1. Introduction
  • 6.2. Plastic
  • 6.3. Glass
  • 6.4. Metal
  • 6.5. Paper & Paperboard
  • 6.6. Others

7. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY PACKAGING TYPE

  • 7.1. Introduction
  • 7.2. Primary Packaging
  • 7.3. Secondary Packaging
  • 7.4. Tertiary Packaging

8. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Material Type
    • 8.2.3. By Packaging Type
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Material Type
    • 8.3.3. By Packaging Type
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Material Type
    • 8.4.3. By Packaging Type
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Material Type
    • 8.5.3. By Packaging Type
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Material Type
    • 8.6.3. By Packaging Type
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Piramal Pharma Solutions
  • 10.2. Almac Group
  • 10.3. Thermo Fisher Scientific Inc.
  • 10.4. Clinigen Clinical Supplies Management
  • 10.5. Xerimis
  • 10.6. PCI Services
  • 10.7. SGS SA (Quay Pharma)
  • 10.8. Bilcare Ltd
  • 10.9. Lonza
  • 10.10. Mikart, LLC

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations